B539 refurbishment & infrastructure upgrades to B539/1ST floor, phase 1
Ended Awarded Last action
- Contract number
- HHSN26100052
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $7,158,692
Award facts
- Opportunity
-
- N01CO5240180 Solicitation number
- Operations and Technical Support for the Frederick National Laboratory for Cancer Research (FLNCR), a Federally Funded Research and Development Center (FFRDC) Award Notice · Posted Apr 27, 2015
- Contract value 100% obligated
- $7,158,692.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 561210 Facilities Support Services
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $24,579 | |
| Other Administrative Action | $16,440 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $421,974 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Change Order | $773,548 | |
| Original award | $5,922,151 |
About this award
The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on September 15, 2017, for refurbishment and infrastructure upgrades to Building 539, 1st Floor, Phase 1, with a ceiling value of $7.16 million under cost-plus-fixed-fee pricing.
Place of performance is Frederick, MD. The ultimate completion date is September 30, 2020. Leidos Biomedical Research Inc. operates as a Federally Funded Research and Development Center (FFRDC) contractor serving the National Cancer Institute and National Institutes of Health, providing biomedical research and facilities support services.
In fiscal year 2020, the order generated $1.9 million in invoiced labor, with one subcontractor reported.
Quick answers
Who was awarded contract HHSN26100052?
HHSN26100052 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 15, 2017.
How much is contract HHSN26100052 worth?
The government has obligated $7,158,692 on HHSN26100052.
Is contract HHSN26100052 an order under another contract?
Yes. HHSN26100052 is a delivery order under HHSN261201500003I, an indefinite delivery contract.
Was contract HHSN26100052 competed?
The extent of competition for HHSN26100052 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award